Abstract:Objective To evaluate the application value of monoexponential, fractional order calculus (FROC) diffusion models and PET imaging to distinguish between benign and malignant solitary pulmonary lesions (SPLs) and malignant SPLs with different pathological types and explore the correlation between each parameter and Ki67 expression. Methods A total of 112 patients were enrolled in this study. Prior to treatment, all patients underwent a dedicated thoracic 18 F-FDG PET/MR examination. Five parameters [including apparent diffusion coefficient (ADC) derived from the monoexponential model; diffusion coefficient (D), a microstructural quantity (μ), and fractional order parameter (β) derived from the FROC model and maximum standardized uptake value (SUVmax) derived from PET] were compared between benign and malignant SPLs and different pathological types of malignant SPLs. Independent sample t test, Mann-Whitney U test, DeLong test and receiver operating characteristic (ROC) curve analysis were used for statistical evaluation. Pearson correlation analysis was used to calculate the correlations between Ki-67 and ADC, D, μ, β, and SUVmax. Results The ADC and D values were significantly higher and the μ and SUVmax values were significantly lower in the benign group [1.57 (1.37, 2.05) μm 2 /ms, 1.59 (1.52, 1.72) μm 2 /ms, 5.06 (3.76, 5.66) μm, 5.15 ± 2.60] than in the malignant group [1.32 (1.03, 1.51) μm 2 /ms, 1.43 (1.29, 1.52) μm 2 /ms, 7.06 (5.87, 9.45) μm, 9.85 ± 4.95]. The ADC, D and β values were significantly lower and the μ and SUVmax values were significantly higher in the squamous cell carcinoma (SCC) group [1.29 (0.66, 1.42) μm 2 /ms, 1.32 (1.02, 1.42) μm 2 /ms, 0.63 ± 0.10, 9.40 (7.76, 15.38) μm, 11.70 ± 5.98] than in the adenocarcinoma (AC) group [1.40 (1.28, 1.67) μm 2 /ms, 1.52 (1.44, 1.64) μm 2 /ms, 0.70 ± 0.10, 5.99 (4.54, 6.87) μm, 8.76 ± 4.18]. ROC curve analysis showed that for a single parameter, μ exhibited the best AUC value in discriminating between benign and malignant SPLs groups and AC and SCC groups (AUC = 0.824 and 0.911, respectively). Importantly, the combination of monoexponential, FROC models and PET imaging can further improve diagnostic performance (AUC = 0.872 and 0.922, respectively). The Pearson correlation analysis showed that Ki67 was positively correlated with μ value and negatively correlated with ADC and D values (r = 0.402, -0.346, -0.450, respectively). Conclusion The parameters D and μ derived from the FROC model were superior to ADC and SUVmax in distinguishing benign from malignant SPLs and adenocarcinoma from squamous cell carcinoma, in addition, the combination of multiple parameters can further improve diagnostic performance. The non-Gaussian FROC diffusion model is expected to become a noninvasive quantitative imaging technique for identifying SPLs.

Tri‐Compartmental Restriction Spectrum Imaging Based on 18F‐FDG PET/MR for Identification of Primary Benign and Malignant Lung Lesions

Quantitative Assessment of Restriction Spectrum MR Imaging for the Diagnosis of Breast Cancer and Association With Prognostic Factors

The value of diffusion kurtosis imaging, diffusion weighted imaging and 18F-FDG PET for differentiating benign and malignant solitary pulmonary lesions and predicting pathological grading

A Comparative Study of Amide Proton Transfer Weighted Imaging and Intravoxel Incoherent Motion MRI Techniques Versus (18) F‐FDG PET to Distinguish Solitary Pulmonary Lesions and Their Subtypes

Diagnostic Performance of Diffusion-Weighted Magnetic Resonance Imaging in Pulmonary Malignant Lesions: a Meta-Analysis.

A comparison study of monoexponential and fractional order calculus diffusion models and 18F-FDG PET in differentiating benign and malignant solitary pulmonary lesions and their pathological types

An 18F-FDG-PET/CT-based radiomics signature for estimating malignance probability of solitary pulmonary nodule

Application of Simultaneous 18 F‐FDG PET With Monoexponential, Biexponential, and Stretched Exponential Model‐Based Diffusion‐Weighted MR Imaging in Assessing the Proliferation Status of Lung Adenocarcinoma

Predictive Value of <scp><sup>18</sup>F‐FDG PET</scp>/<scp>MRI</scp> for Pleural Invasion in Solid and Subsolid Lung Adenocarcinomas Smaller Than 3 cm

Radiomics Analysis Based on 18F-FDG and 18F-FLT PET/CT Images May Facilitate the Differentiation of Benign and Malignant Pulmonary Nodules

Predictive Value of 18F‐FDG PET/MRI for Pleural Invasion in Solid and Subsolid Lung Adenocarcinomas Smaller Than 3 cm

Predictive Value of <SUP>18</SUP>F-FDG PET/MRI for Pleural Invasion in Solid and Subsolid Lung Adenocarcinomas Smaller Than 3 cm

Value of TNR and TLR of 18F-FDG PET/CT Tumor Metabolic Imaging in Diagnosis of Lung Cancer

[FDG-PET in the Diagnosis of Pulmonary Lesions].

Application of Dynamic [18F]FDG PET/CT Multiparametric Imaging Leads to an Improved Differentiation of Benign and Malignant Lung Lesions

~(18)FDG-SPECT with coincidence in detection of lung lesions

Diagnostic ability of dual-phase 18F-fluoro-2-deoxy-D-glucose SPECT/PET for distinguishing benign and malignant lesions

Predictive Value of 18 F-FDG PET/MRI for Pleural Invasion in Solid and Subsolid Lung Adenocarcinomas Smaller Than 3 cm.

Quantitative parameters of static imaging and fast kinetics imaging in <SUP>18</SUP>F-FDG total-body PET/CT for the assessment of histological feature of pulmonary lesions

Diagnosis Ability of Dual-Phase F-18-fluoro-2-deoxy-D-glucose SPECT/PET for Distinguishing the Benign and Malignant Lesions

Comparison Of Positron Emission Tomography Using 2-[F-18]-Fluoro-2-Deoxy-D-Glucose And 3-Deoxy-3-[F-18]-Fluorothymidine In Lung Cancer Imaging